BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19032782)

  • 1. Identification of possible candidate genes regulating Sjögren's syndrome-associated autoimmunity: a potential role for TNFSF4 in autoimmune exocrinopathy.
    Nguyen CQ; Cornelius JG; Cooper L; Neff J; Tao J; Lee BH; Peck AB
    Arthritis Res Ther; 2008; 10(6):R137. PubMed ID: 19032782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sjögren's syndrome-like disease of C57BL/6.NOD-Aec1 Aec2 mice: gender differences in keratoconjunctivitis sicca defined by a cross-over in the chromosome 3 Aec1 locus.
    Nguyen C; Singson E; Kim JY; Cornelius JG; Attia R; Doyle ME; Bulosan M; Cha S; Peck AB
    Scand J Immunol; 2006 Sep; 64(3):295-307. PubMed ID: 16918699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.
    Cha S; Nagashima H; Brown VB; Peck AB; Humphreys-Beher MG
    Arthritis Rheum; 2002 May; 46(5):1390-8. PubMed ID: 12115247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sjögren's syndrome (SJS)-like disease of the C57BL/6.NOD-Aec1Aec2 mouse.
    Nguyen CQ; Sharma A; She JX; McIndoe RA; Peck AB
    Exp Eye Res; 2009 Mar; 88(3):398-409. PubMed ID: 19103199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential gene expression in the salivary gland during development and onset of xerostomia in Sjögren's syndrome-like disease of the C57BL/6.NOD-Aec1Aec2 mouse.
    Nguyen CQ; Sharma A; Lee BH; She JX; McIndoe RA; Peck AB
    Arthritis Res Ther; 2009; 11(2):R56. PubMed ID: 19379516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3.
    Nguyen CQ; Kim H; Cornelius JG; Peck AB
    J Immunol; 2007 Aug; 179(4):2318-29. PubMed ID: 17675493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy.
    Lee BH; Carcamo WC; Chiorini JA; Peck AB; Nguyen CQ
    Arthritis Res Ther; 2012 Jul; 14(4):R172. PubMed ID: 22827855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy.
    Brayer J; Lowry J; Cha S; Robinson CP; Yamachika S; Peck AB; Humphreys-Beher MG
    J Rheumatol; 2000 Aug; 27(8):1896-904. PubMed ID: 10955330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling of early-phase Sjögren's syndrome in C57BL/6.NOD-Aec1Aec2 mice identifies focal adhesion maturation associated with infiltrating leukocytes.
    Peck AB; Saylor BT; Nguyen L; Sharma A; She JX; Nguyen CQ; McIndoe RA
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5647-55. PubMed ID: 21666236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of complement and B lymphocytes in Sjögren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2b mice.
    Nguyen C; Cornelius J; Singson E; Killedar S; Cha S; Peck AB
    Mol Immunol; 2006 Mar; 43(9):1332-9. PubMed ID: 16221495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early pathogenic events associated with Sjögren's syndrome (SjS)-like disease of the NOD mouse using microarray analysis.
    Killedar SJ; Eckenrode SE; McIndoe RA; She JX; Nguyen CQ; Peck AB; Cha S
    Lab Invest; 2006 Dec; 86(12):1243-60. PubMed ID: 17075579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjögren's syndrome-like disease of the nonobese diabetic mouse.
    Nguyen CQ; Gao JH; Kim H; Saban DR; Cornelius JG; Peck AB
    J Immunol; 2007 Jul; 179(1):382-90. PubMed ID: 17579059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of autoimmune sialadenitis in nonobese diabetic mice: a major susceptibility region on chromosome 1.
    Boulard O; Fluteau G; Eloy L; Damotte D; Bedossa P; Garchon HJ
    J Immunol; 2002 Apr; 168(8):4192-201. PubMed ID: 11937580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.
    Gao J; Killedar S; Cornelius JG; Nguyen C; Cha S; Peck AB
    J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjögren's syndrome.
    Brayer JB; Cha S; Nagashima H; Yasunari U; Lindberg A; Diggs S; Martinez J; Goa J; Humphreys-Beher MG; Peck AB
    Scand J Immunol; 2001; 54(1-2):133-40. PubMed ID: 11439159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective Efferocytosis in a Murine Model of Sjögren's Syndrome Is Mediated by Dysfunctional Mer Tyrosine Kinase Receptor.
    Witas R; Rasmussen A; Scofield RH; Radfar L; Stone DU; Grundahl K; Lewis D; Sivils KL; Lessard CJ; Farris AD; Nguyen CQ
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidate chromosome 1 disease susceptibility genes for Sjogren's syndrome xerostomia are narrowed by novel NOD.B10 congenic mice.
    Mongini PK; Kramer JM; Ishikawa TO; Herschman H; Esposito D
    Clin Immunol; 2014 Jul; 153(1):79-90. PubMed ID: 24685748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
    Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
    Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional landscapes of emerging autoimmunity: transient aberrations in the targeted tissue's extracellular milieu precede immune responses in Sjögren's syndrome.
    Delaleu N; Nguyen CQ; Tekle KM; Jonsson R; Peck AB
    Arthritis Res Ther; 2013 Oct; 15(5):R174. PubMed ID: 24286337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic control of disease in an experimental model for Sjögren's syndrome.
    Andersson A
    Arthritis Res Ther; 2009; 11(1):102. PubMed ID: 19216731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.